| # | Drug | Count |
|---|---|---|
| 0 | FOLIC ACID | 19 |
| 1 | ADALIMUMAB | 18 |
| 2 | ETANERCEPT | 17 |
| 3 | INFLIXIMAB | 17 |
| 4 | NAPROXEN SODIUM | 17 |
| 5 | TOCILIZUMAB | 17 |
| 6 | ABATACEPT | 16 |
| 7 | ANAKINRA | 16 |
| 8 | METHOTREXATE | 16 |
| 9 | METHOTREXATE SODIUM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 14 | 0.0534 |
| 1 | TETANUS IMMUNE GLOBULIN (HUMAN) | 4 | 0.0367 |
| 2 | ANAKINRA | 16 | 0.0009 |
| 3 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 6 | 0.0009 |
| 4 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 15 | 0.0006 |
| 5 | NAPROXEN SODIUM 220MG | 7 | 0.0005 |
| 6 | TRIAMCINOLONE ACETONIDE | 15 | 0.0005 |
| 7 | ADALIMUMAB-FKJP | 14 | 0.0003 |
| 8 | ADALIMUMAB-AATY | 14 | 0.0003 |
| 9 | ADALIMUMAB-ADAZ | 15 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 19 |
| 1 | Vitamin B12 [EPC] | 19 |
| 2 | Vitamin C [EPC] | 19 |
| 3 | Vitamin D [EPC] | 19 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 17 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 17 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 16 |
| 9 | Selective T Cell Costimulation Modulator [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 16 | 0.0009 |
| 1 | Human Immunoglobulin G [EPC] | 6 | 0.0003 |
| 2 | Aminosalicylate [EPC] | 15 | 0.0001 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 17 | 0.0001 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 16 | 0.0001 |
| 5 | Anti-IgE [EPC] | 7 | 0.0001 |
| 6 | Vitamin D [EPC] | 19 | 0.0001 |
| 7 | Vitamin B12 [EPC] | 19 | 0.0001 |
| 8 | Vitamin C [EPC] | 19 | 0.0000 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 16 | 0.0000 |